{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-26-000837","form_type":"8-K","ticker":"KALA","cik":"0001479419","company_name":"KALA BIO, Inc.","filed_at":"2026-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.169678+00:00","generated_at":"2026-05-16T05:34:59.918991+00:00","sec_items":["1.01","3.02","5.01","5.02","5.03","5.07","9.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.9,"confidence":"high","headline":"KALA BIO sells $4.2M Series AAA Preferred, board control shifts to AK Holdings","bullets":["Company issued 2.1M shares of Series AAA Preferred at $2/sh, raising $4.2M; each share convertible into 420 common shares (882M total potential shares).","AK Holdings appointed five directors: Avi Minkowitz, Hillel Posen, Chaim Berger, Yonatan Colman, Brendan Purdy, replacing prior board.","Stockholders approved increase in authorized common shares to 1.5B and authorized reverse stock split (1:2 to 1:100).","Six prior directors resigned (Marjan Farid, Andrew Koven, Mark Iwicki, Todd Bazemore, C. Daniel Meyers, Howard Rosen)."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-000837","json":"https://secwatch.observer/filing/0001829126-26-000837.json","markdown":"https://secwatch.observer/filing/0001829126-26-000837.md","text":"https://secwatch.observer/filing/0001829126-26-000837.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000837/0001829126-26-000837-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000837/kalabio_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T05:34:59.918991+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}